Angella Angiji

Angella Angiji is an experienced professional in drug safety and pharmacovigilance, currently serving as Associate Director at Genmab since June 2023. Previously, Angella held the position of Safety Scientist at Seqirus from February 2020 to May 2023, and worked as a Consultant at ProPharma Group from January 2019 to January 2020. Earlier roles include Associate Consultant and Drug Safety Associate at Xendo, with a focus on adverse events management. Angella's academic background includes a Master's degree in Pharmacovigilance from the University of Hertfordshire and a Master's degree in Molecular Life Sciences from Wageningen University & Research, complemented by a Bachelor's degree in Process and Food Technology from Haagse Hogeschool Den Haag. Earlier internships included research at Prosensa Therapeutics B.V. and Shell Global Solutions, along with practical experience at Croda.